Edition:
United States

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

4.53USD
23 Apr 2018
Change (% chg)

$-0.23 (-4.83%)
Prev Close
$4.76
Open
$4.75
Day's High
$4.75
Day's Low
$4.47
Volume
298,137
Avg. Vol
352,373
52-wk High
$8.37
52-wk Low
$3.92

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 18.68 -1.192
Sep '17 15.00 -0.197
Jun '17 15.14 -0.768
Mar '17 11.82 -0.215
FY 2016 Dec '16 9.53 -0.319
Sep '16 6.34 -0.394
Jun '16 9.29 -0.422
Mar '16 6.82 -0.388
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 25.24 26.54 23.00 29.89
Quarter Ending Sep-18 5 28.90 30.70 27.00 33.42
Year Ending Dec-18 7 106.87 114.31 94.50 124.92
Year Ending Dec-19 7 171.55 239.70 128.70 196.83
Earnings (per share)
Quarter Ending Jun-18 8 -0.16 -0.13 -0.22 -0.05
Quarter Ending Sep-18 8 -0.13 -0.10 -0.19 -0.02
Year Ending Dec-18 7 -0.59 -0.47 -0.81 -0.25
Year Ending Dec-19 7 -0.20 -0.03 -0.32 0.10
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 185.04 32.78
P/E High - Last 5 Yrs. -- 284.68 45.94
P/E Low - Last 5 Yrs. -- 95.75 24.95
Beta 2.59 0.75 0.80
Price to Sales (TTM) 9.35 136.40 7.08
Price to Book (MRQ) -- 19.34 5.00
Price to Tangible Book (MRQ) -- 24.06 6.75
Price to Cash Flow (TTM) -- 122.96 25.60
% Owned Institutions 67.13 11.18 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.55
Dividend Yield - 5 Year Avg -- 0.20 0.74
Dividend 5 Year Growth Rate -- 1.94 3.92
Payout Ratio(TTM) -- 9.18 20.28

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 95.97 103.99 9.00
Sales (TTM) vs TTM 1 Yr. Ago 89.60 80.63 10.85
Sales - 5 Yr. Growth Rate -- 33.87 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -273.84 -66.82 22.25
EPS (TTM) vs TTM 1 Yr. Ago -55.88 -- --
EPS - 5 Yr. Growth Rate -- 47.44 10.24
Capital Spending - 5 Yr. Growth Rate 120.71 45.48 10.39

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.49 1.63 2.53
Current Ratio (MRQ) 3.12 5.97 3.62
LT Debt to Equity (MRQ) -- 23.32 11.28
Total Debt to Equity (MRQ) -- 25.75 13.94
Interest Coverage (TTM) -30.54 -181.71 30.08

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 58.72 36.28 53.98
Gross Margin - 5 Yr. Avg. -- 55.36 52.10
EBITD Margin (TTM) -166.15 -- --
EBITD - 5 Yr. Avg -395.50 -149.35 15.94
Operating Margin (TTM) -167.69 -564.83 4.32
Operating Margin - 5 Yr. Avg. -397.84 -161.27 11.31
Pre-Tax Margin (TTM) -269.91 -537.64 4.97
Pre-Tax Margin - 5 Yr. Avg. -487.63 -168.32 11.62
Net Profit Margin (TTM) -453.72 -526.60 1.58
Net Profit Margin - 5 Yr. Avg. -578.13 -168.70 7.94
Effective Tax Rate (TTM) -- -0.44 31.27
Effective Tax Rate - 5 Yr. Avg. -- 18.13 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 288,767 23,918,133 819,537,692
Net Income/Employee (TTM) -1,310,191 754,796 96,346,718
Receivable Turnover (TTM) 9.06 6.24 5.57
Inventory Turnover (TTM) 1.21 2.37 3.45
Asset Turnover (TTM) 0.40 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -183.24 -0.77 10.55
Return on Assets - 5 Yr. Avg. -109.86 0.69 11.58
Return on Investment (TTM) -235.84 -0.74 13.21
Return on Investment - 5 Yr. Avg. -148.67 4.20 14.99
Return on Equity (TTM) -- -2.80 15.01
Return on Equity - 5 Yr. Avg. -366.66 -0.05 16.27
  1 Year 3 Year 5 Year
Sales % 89.60 77.60 --
EPS (TTM) % -57.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Keryx Biopharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.12%
# of Holders: 180
Total Shares Held: 79,992,650
3 Mo. Net Change: 256,308
# New Positions: 3
# Closed Positions: 3
# Increased Positions: 10
# Reduced Positions: 11
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.